Push To Create Ultra-Rare Orphan Drug Designation Finds Resistance At US FDA

 
• By Derrick Gingery

Agency officials don’t think a new definition or incentives will fix the issues related to development in rare diseases with only a handful of patients, as advocates continue pushing the idea.

roadblock
Without FDA support, passing legislation to create ultra-orphan incentives will become more difficult. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet